EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Randomisierte kontrollierte StudieOpen Access · CC BY-NC 3.0

First-in-Human Phase 1 Evaluation of the DegradaBALL Mesoporous Silica Nanoparticle Delivery System: An mRNA SARS-CoV-2 Vaccine Study in Healthy Korean Adult Volunteers

Sooyoun Lee iD, Ki Young Huh iD, Kyung-Sang Yu iD, Dal-Hee Min iD, Cheolhee Won iD, In-Jin Jang iD

Drug Design, Development and Therapy · 2026-10 · Volume 20 · 1-15

DOI: 10.2147/dddt.s631473 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Drug Design, Development and Therapy, 2026-10. Verfasst von Sooyoun Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Nanoparticles, SARS-CoV-2. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19COVID-19 VaccinesNanoparticlesSARS-CoV-2Silicon DioxideAdultFemaleHumansMaleMiddle AgedYoung AdultDose-Response Relationship, DrugDouble-Blind MethodHealthy VolunteersNanovaccinesPorosityRepublic of KoreaRNA, Messenger

Stichwörter der Autor:innen

COVID-19DegradaBALLdrug deliveryfirst-in-humanmRNA vaccinemesoporous silica nanoparticle

Substanzen

COVID-19 VaccinesNanovaccinesRNA, MessengerSilicon Dioxide

Autor:innen und Institutionen

  • Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
  • Department of Chemistry, Seoul National University, Seoul, Republic of Korea.
  • Lemonex Inc., Institute of Biotherapeutics Convergence Technology, Seoul, Republic of Korea.

ORCID-Profile: Sooyoun Lee, Ki Young Huh, Kyung-Sang Yu, Dal-Hee Min, Cheolhee Won, In-Jin Jang

Zitieren

APA

Lee, S., Huh, K. Y., Yu, K. S., Min, D. H., Won, C., & Jang, I. J. (2026). First-in-Human Phase 1 Evaluation of the DegradaBALL Mesoporous Silica Nanoparticle Delivery System: An mRNA SARS-CoV-2 Vaccine Study in Healthy Korean Adult Volunteers. Drug Design, Development and Therapy, Volume 20, 1-15. https://doi.org/10.2147/dddt.s631473

Vancouver

Lee S, Huh KY, Yu KS, Min DH, Won C, Jang IJ. First-in-Human Phase 1 Evaluation of the DegradaBALL Mesoporous Silica Nanoparticle Delivery System: An mRNA SARS-CoV-2 Vaccine Study in Healthy Korean Adult Volunteers. Drug Design, Development and Therapy. 2026;Volume 20:1-15. doi:10.2147/dddt.s631473

BibTeX
@article{Lee2026,
  author = {Lee, Sooyoun and Huh, Ki Young and Yu, Kyung-Sang and Min, Dal-Hee and Won, Cheolhee and Jang, In-Jin},
  title = {First-in-Human Phase 1 Evaluation of the DegradaBALL Mesoporous Silica Nanoparticle Delivery System: An mRNA SARS-CoV-2 Vaccine Study in Healthy Korean Adult Volunteers},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--15},
  doi = {10.2147/dddt.s631473}
}
Kostenlos starten →